Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles

[1]  Alke Petri-Fink,et al.  Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine. , 2017, Chemical reviews.

[2]  Jonathan Shannahan,et al.  The biocorona: a challenge for the biomedical application of nanoparticles , 2017, Nanotechnology reviews.

[3]  R. Ivkov,et al.  Experimental estimation and analysis of variance of the measured loss power of magnetic nanoparticles , 2017, Scientific Reports.

[4]  Rocío Costo,et al.  Distribution functions of magnetic nanoparticles determined by a numerical inversion method , 2017 .

[5]  A. Seifalian,et al.  Magnetic Nanoparticles: New Perspectives in Drug Delivery. , 2017, Current pharmaceutical design.

[6]  Andris F. Bakuzis,et al.  AC susceptibility as a tool to probe the dipolar interaction in magnetic nanoparticles , 2016, 1604.02978.

[7]  M. Arciniegas,et al.  Dipolar interaction and demagnetizing effects in magnetic nanoparticle dispersions: Introducing the mean-field interacting superparamagnet model , 2015, 1507.05192.

[8]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[9]  L. Bezdetnaya,et al.  Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics , 2015, Drugs.

[10]  M. Radomski,et al.  Magnetic Nanoparticles in Cancer Theranostics , 2015, Theranostics.

[11]  R. Ivkov,et al.  Internal Magnetic Structure of Nanoparticles Dominates Time‐Dependent Relaxation Processes in a Magnetic Field , 2015 .

[12]  P. J. Hoopes,et al.  The Dartmouth Center for Cancer Nanotechnology Excellence: magnetic hyperthermia. , 2015, Nanomedicine.

[13]  Rishi Shanker,et al.  Toxicity of Nanomaterials , 2015, BioMed research international.

[14]  Daniele Marin,et al.  Emerging applications for ferumoxytol as a contrast agent in MRI , 2015, Journal of magnetic resonance imaging : JMRI.

[15]  R. Ivkov,et al.  Evaluation of a PSMA-targeted BNF nanoparticle construct. , 2015, Nanoscale.

[16]  Christian NDong,et al.  Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo , 2015, PloS one.

[17]  R. Ivkov,et al.  Physics of heat generation using magnetic nanoparticles for hyperthermia , 2013, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[18]  Lily Yang,et al.  Anti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancer , 2013, International journal of nanomedicine.

[19]  C. Batich,et al.  Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia , 2013, International journal of molecular sciences.

[20]  Kannan M. Krishnan,et al.  Size-Dependent Relaxation Properties of Monodisperse Magnetite Nanoparticles Measured Over Seven Decades of Frequency by AC Susceptometry , 2013, IEEE Transactions on Magnetics.

[21]  Anilchandra Attaluri,et al.  New iron-oxide particles for magnetic nanoparticle hyperthermia: an in-vitro and in-vivo pilot study , 2013, Photonics West - Biomedical Optics.

[22]  Mohammad Hedayati,et al.  Preliminary study of injury from heating systemically delivered, nontargeted dextran-superparamagnetic iron oxide nanoparticles in mice. , 2012, Nanomedicine.

[23]  P. L. McCormack,et al.  Ferumoxytol: in iron deficiency anaemia in adults with chronic kidney disease. , 2012, Drugs.

[24]  R. Ivkov,et al.  Modified Solenoid Coil That Efficiently Produces High Amplitude AC Magnetic Fields With Enhanced Uniformity for Biomedical Applications , 2012, IEEE Transactions on Magnetics.

[25]  Theodore L. DeWeese,et al.  Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields , 2011 .

[26]  J. Kornhuber,et al.  Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system , 2010, Journal of cellular physiology.

[27]  William D Rooney,et al.  Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[29]  John Crittenden,et al.  Impact of natural organic matter and divalent cations on the stability of aqueous nanoparticles. , 2009, Water research.

[30]  B. Sproat,et al.  Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. , 2009, Molecular pharmaceutics.

[31]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[32]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[33]  S. Ganta,et al.  A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[34]  C. Köhler.  Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis , 2007, Cell and Tissue Research.

[35]  Robert Ivkov,et al.  Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy , 2007 .

[36]  J. Dormann,et al.  Magnetic Relaxation in Fine‐Particle Systems , 2007 .

[37]  Arutselvan Natarajan,et al.  Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  Y. Qiang,et al.  The effect of particle size distribution on the usage of the ac susceptibility in biosensors , 2006 .

[39]  P Wust,et al.  Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[40]  Wolfgang Daum,et al.  Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer , 2005, Clinical Cancer Research.

[41]  R. Ivkov,et al.  Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.

[42]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[43]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[44]  A. Curtis,et al.  Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture , 2004, Journal of materials science. Materials in medicine.

[45]  Marie-Isabelle Baraton,et al.  Synthesis, Functionalization and Surface Treatment of Nanoparticles , 2002 .

[46]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[47]  S. Andò,et al.  Characteristics and biodistribution of cationic liposomes and their DNA complexes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[48]  A. Maitra,et al.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.

[49]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[50]  G. Merlo,et al.  Polyethylenimine-based intravenous delivery of transgenes to mouse lung , 1998, Gene Therapy.

[51]  G. Gebhart,et al.  Special Report: The 1996 Guide for the Care and Use of Laboratory Animals. , 1997, ILAR journal.

[52]  L. Perlemuter.  [From theory to practice]. , 1997, Soins. Psychiatrie.

[53]  I. Lucet,et al.  Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. , 1996, Journal of microencapsulation.

[54]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[55]  J. A. V. BUTLER,et al.  Theory of the Stability of Lyophobic Colloids , 1948, Nature.

[56]  B. Derjaguin,et al.  Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solutions of electrolytes , 1993 .